Assignee
TURNER SEAN COLM
DE·7 granted patents·2 pending applications·49 citations·filing 2008–2012
Top patents by PatentIndex Score
9 records- 0188US9090592B2Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsTURNER SEAN COLM·Filed 2011·Granted Jul 28, 2015·6 cites·29 claims
- 0288US8440694B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptorTURNER SEAN COLM·Filed 2012·Granted May 14, 2013·12 cites·13 claims
- 0388US8318793B2Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsTURNER SEAN COLM·Filed 2010·Granted Nov 27, 2012·17 cites·19 claims
- 0486US9266855B2Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsTURNER SEAN COLM·Filed 2011·Granted Feb 23, 2016·11 cites·22 claims
- 0574US8242102B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptorTURNER SEAN COLM·Filed 2008·Granted Aug 14, 2012·2 cites·23 claims
- 0671US8455648B21-(7-(hexahydropyrrolo [3,4-c] pyrrol-2 (1H)-yl) quinolin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (GSK-3)TURNER SEAN COLM·Filed 2009·Granted Jun 4, 2013·1 cites·19 claims
- 0761US2010210664A1Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptorTURNER SEAN COLM·Filed 2008·Application pending·0 cites
- 0858US8293913B2Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptorTURNER SEAN COLM·Filed 2008·Granted Oct 23, 2012·0 cites·13 claims
- 0953US2011319421A1Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptorTURNER SEAN COLM·Filed 2011·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →